SC
Suresh Chandanmal Sanghvi
About Suresh Chandanmal Sanghvi
Data last updated:
Suresh Chandanmal Sanghvi was a Designated Partner at Lifepoint Research Llp (2015–2024), Director at Pooja Priya Dwellers Private Limited (2002–2024) and Designated Partner at Alpine Retreat Llp (2016–2024), and held 3 more directorships. The companies operate in Healthcare, Real Estate and Construction and Travel and Hospitality.
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Designated Partner | 07 Jul 2015 | 2015 | Active | ||
| Director | 30 Aug 2002 | 2002 | Active | ||
| Designated Partner | 11 Aug 2016 | 2016 | Active | ||
| Director | 29 Mar 2004 | 2004 | ₹1.17 Cr (FY 2024) | Active | |
| Director | 16 Nov 2007 | 2007 | ₹4.68 Cr (FY 2024) | Active | |
| Director | 15 May 2008 | 2008 | ₹11,047 (FY 2016) | Converted To Llp |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Suresh Chandanmal Sanghvi
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Suresh Chandanmal Sanghvi
Suresh Chandanmal Sanghvi was first appointed on 30 Aug 2002 as Director at Pooja Priya Dwellers Private Limited. The most recent appointment on record is 11 Aug 2016 at Alpine Retreat Llp.
Suresh Chandanmal Sanghvi held 6 earlier board appointments: Lifepoint Research Llp (Designated Partner, 07 Jul 2015 to 03 Mar 2024); Pooja Priya Dwellers Private Limited (Director, 30 Aug 2002 to 03 Mar 2024); Alpine Retreat Llp (Designated Partner, 11 Aug 2016 to 03 Mar 2024); Karishma Laser & Cosmetic Private Limited (Director, 29 Mar 2004 to 03 Mar 2024); Lifepoint Multispeciality Hospital Private Limited (Director, 16 Nov 2007 to 03 Mar 2024); and 1 more.